Sunscreen product recalled due to manufacturing practice violations
GreenScreen sunscreen (Zinc Oxide SPF 32) is being recalled by KABANA SKIN CARE due to manufacturing practice deviations. The recall affects 174 tubes distributed in New Jersey, Florida, and Michigan.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is a Class II voluntary recall initiated by the manufacturer for manufacturing practice deviations. No specific contamination hazard is identified in the source, and the recall is precautionary in nature. Per the rubric, voluntary precautionary recalls are scored as Moderate.
Plain-English summary
KABANA SKIN CARE has initiated a voluntary recall of GreenScreen sunscreen (Zinc Oxide SPF 32, NDC 73369-0001-1) affecting 174 tubes. The affected lots are 405-002 and 405-003.
The recall was issued due to deviations from current Good Manufacturing Practice (cGMP) standards. The affected product was distributed in New Jersey, Florida, and Michigan.
The recalled product
- Product
- GreenScreen, kabana organic skincare, Bread Spectrum UVA & UVB, Zinc Oxide Sunscreen, Organic Ingredients, Fragrance Free, Biodegradable, Chemical Free, Non-Nano, Baby Safe, Original, SPF 32, Totally Green personal care, Zinc Oxide USP 25%, 3.4 FL OZ/115 G Tube, NDC: 73369-0001-1
- Manufacturer
- KABANA SKIN CARE
- Category
- Drug — Sunscreen / Topical
- Hazard
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lots: 405-002 and 405-003
Distribution
Distributed in 3 states:
- FL
- MI
- NJ
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27